Biodesix BDSX
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Biodesix (BDSX) Business Model and Operations Summary
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Key Insights
Biodesix (BDSX) Core Market Data and Business Metrics
Latest Closing Price
$0.6277Market Cap
$88.48 MillionPrice-Earnings Ratio
-1.96Total Outstanding Shares
145.98 Million SharesTotal Employees
273Dividend
No dividendIPO Date
October 28, 2020SIC Description
Services-medical LaboratoriesPrimary Exchange
NASDAQHeadquarters
919 West Dillon Road, Louisville, CO, 80027
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 856,817 Shares | 1.47 | 3/14/2025 | 1,257,555 Shares |
| 188,297 Shares | 5.17 | 2/28/2025 | 973,182 Shares |
| 349,668 Shares | 2.23 | 2/14/2025 | 781,342 Shares |
| 574,260 Shares | 1.3 | 1/31/2025 | 748,374 Shares |
| 381,400 Shares | 1.98 | 1/15/2025 | 756,313 Shares |
| 234,761 Shares | 3.56 | 12/31/2024 | 836,593 Shares |
Cash Flow Statement
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $30.73 Million |
| Net Cash Flow From Operating Activities, Continuing | $-18.57 Million |
| Net Cash Flow From Financing Activities, Continuing | $51.30 Million |
| Net Cash Flow From Investing Activities | $-2.00 Million |
| Net Cash Flow From Operating Activities | $-18.57 Million |
| Net Cash Flow From Investing Activities, Continuing | $-2.00 Million |
Income Statement
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Basic Earnings Per Share | $-0.08 |
| Income Tax Expense/Benefit | $0 |
| Interest Expense, Operating | $1.94 Million |
| Benefits Costs and Expenses | $0 |
| Operating Income/Loss | $-8.24 Million |
| Depreciation and Amortization | $1.41 Million |
Comprehensive Income
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-10.81 Million |
| Comprehensive Income/Loss Attributable To Parent | $-10.81 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $0 |
Balance Sheet
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $0 |
| Liabilities | $79.58 Million |
| Equity | $36.26 Million |
| Accounts Payable | $2.22 Million |
| Noncurrent Liabilities | $62.03 Million |
| Wages | $4.65 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||